Loading...
Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617
Prostate cancer (PC) is one of the most common malignancies affecting men, with poor prognosis after progression to metastatic castration-resistant prostate cancer (mCRPC). Radioligand therapy (RLT) targeting the overexpressed PSMA on PC cells, with, e.g., <sup>177</sup>Lu-PSMA-617, has...
Na minha lista:
Main Authors: | , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
MDPI AG
2022-03-01
|
Serier: | Pharmaceutics |
Fag: | |
Online adgang: | https://www.mdpi.com/1999-4923/14/4/731 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|